NCT02711358View on ClinicalTrials.gov

Indomethacin Use in Pain Relief During Intrauterine Device Insertion

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

July 31, 2016

Study Completion Date

October 31, 2016

Conditions
Family Planning
Interventions
DRUG

indomethacin suppositories

The patients will be instructed to self-administer a single rectal dose of 50 mg indomethacin 30 min before the scheduled time of the procedure

DRUG

placebo

The patient swill be instructed to self-administer a single rectal dose of placebo 30 min before the scheduled time of the procedure

Trial Locations (1)

002

Ahmed Abbas, Assiut

All Listed Sponsors
lead

Assiut University

OTHER

NCT02711358 - Indomethacin Use in Pain Relief During Intrauterine Device Insertion | Biotech Hunter | Biotech Hunter